Lm. Prisant et al., ASSESSMENT OF LATE POTENTIALS IN PATIENTS WITH ESSENTIAL-HYPERTENSIONBY THE SIGNAL-AVERAGED ELECTROCARDIOGRAM WITH 5-YEAR FOLLOW-UP, Journal of human hypertension, 7(5), 1993, pp. 497-503
Both the Framingham and Manitoba Heart Studies have identified electro
cardiographic left ventricular (LV) hypertrophy (LVH) as a risk factor
for sudden cardiac death. Low amplitude ventricular late potentials i
n the terminal part of ventricular activation have been associated wit
h sustained ventricular tachycardia and have identified those at risk
for sudden cardiac death. Therefore, we prospectively examined 23 esse
ntial hypertensives without known symptomatic coronary heart disease b
y two-dimensional echocardiography and signal averaged electrocardiogr
ams (SAECGs) for the detection of ventricular late potentials. The SAE
CG vector-magnitude complex measurements included the total duration o
f the complex (QRSd), the voltage in the last 40 ms (V40), and the dur
ation of low amplitude signals < 40 muV in the terminal portion of the
complex (LASd). Echocardiographic parameter means were: LV diastolic
diameter = 46.0 +/- 4.5 mm, combined septal and posterior wall thickne
ss = 23.3 +/- 4.2 mm, LV mass (Woythaler method) = 235.1 +/- 69.1 g, L
V mass (Penn method) = 199.5 +/- 55.3 g and ejection fraction = 63.9 /- 6.2%. SAECG measurement means were QRSd = 88.2 +/- 9.9 ms, V40 = 63
.1 +/- 34.7 muV RMS, and LASd = 23.5 +/- 10.0 ms. No echocardiographic
parameter correlated with SAECG duration; however, age correlated wit
h QRSd (r = 0.48, P = 0.02). Posterior wall thickness (r = -0.43, P =
0.04), LV mass index (r = -0.44, P = 0.03) and LV mass//height (r = -0
.49, P = 0.02) inversely correlated with LASd. Only three patients had
ventricular late potentials and none had an increased LV index by ech
ocardiography or significant ventricular ectopy by ambulatory ECG. All
23 patients were alive with no known arrhythmic event after five year
s; one patient developed unstable angina requiring angioplasty. The ro
le of the SAECG in hypertensive patients remains to be defined.